DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Aplaviroc
Aplaviroc
Review CCR5 Antagonists: Host-Targeted Antivirals for the Treatment of HIV Infection
Aplaviroc (APL, 873140)
A Novel Small Molecule CCR5 Inhibitor Active Against R5-Tropic HIV-1S
Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology Xuanmao Jiao1, Omar Nawab1,2,Tejal Patel2, Andrew V
Background Paper 6.7 Human Immunodeficiency Virus (HIV)/ Acquired Immune Deficiency Syndromes (AIDS)
Full Article In
HIV Entry Inhibitors Stuck in the Pipeline
Antiviral Activity and Safety of Aplaviroc with Lamivudine/Zidovudine in HIV-Infected, Therapy-Naive Patients: the ASCENT (CCR102881) Study
Stembook 2018.Pdf
Hepatotoxicity of Contemporary Antiretroviral Drugs: a Review and Evaluation of Published Clinical Data
CCR5 Inhibitors and HIV-1 Infection
Repurposing of FDA Approved Drugs
Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology
Ccr5 Antagonists in the Treatment of Treatment-Naïve Patients Infected with Ccr5 Tropic Hiv-1
Research Trends and Regulation of CCL5 in Prostate Cancer
BHIVA) Guidelines for the Treatment of HIV-Infected Adults with Antiretroviral Therapy (2006
WO 2017/035230 Al 2 March 2017 (02.03.2017) P O P C T
HIV-1 Entry Inhibition by Small-Molecule CCR5 Antagonists: a Combined Molecular Modeling and Mutant Study Using a High-Throughput Assay
Top View
Parenteral Inhibitors of HIV Entry in Current Development The
HIV-1 Drug Resistance to Integrase Strand Transfer Inhibitors in HIV-1 Non-B Subtypes
HIV-1 Entry, Inhibitors, and Resistance
New Antiretroviral Therapies and Potential Drug Interactions in HIV
Mechanisms of Ccr5 Agonist/Antagonist Inhibition of Hiv-1
The Role of Receptors in the Hiv-1 Entry Process
Antiviral Effects of Polyphenols from Marine Algae
HIV-1 Entry and Prospects for Protecting Against Infection
Human Immunodeficiency Virus
Study Protocol and Results
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Combinatorial Anti-HIV Gene Therapy: Using a Multipronged Approach to Reach Beyond HAART
Chemical Properties Biological Description Solubility Information
Aplaviroc | Medchemexpress
Co-Receptor Signaling in the Pathogenesis of Neurohiv
WO 2017/205585 Al 30 November 20 7 (30
The Expanding Therapeutic Perspective of CCR5 Blockade
Immunology/Inflammation
Datasheet Inhibitors / Agonists / Screening Libraries a DRUG SCREENING EXPERT
Patient Enrollment for Phase III Clinical Studies with New HIV Drug (ONO-4128 / 873140) Terminated
Wo2018/191558
Review a New Era of Antiretroviral Drug Toxicity
Us 2019 / 0127401 A1
Aplaviroc (GSK) Vicriviroc